We recently observed that specific antibodies to type II collagen do not bind in appreciable amounts to the intact surface of articular cartilage, whereas antibodies to the minor collagen types V, VI, and IX do. These results suggest that the outermost cartilage surface layer prevented interaction of the antibodies with the major collagen type in articular cartilage. The present studies were designed to investigate the pathogenic mechanisms involved in the disruption of the cartilage surface layer in inflammatory arthritis. Articular cartilage obtained from rabbits undergoing acute antigen-induced arthritis of 72 h duration showed a significant increase in binding of anti-type II antibody to cartilage surfaces compared with normal control cartilage (P less than 0.01). Augmentation of anti-type II binding was also observed upon in vitro incubation of bovine articular slices or intact rabbit patellar cartilage for 1 h with human polymorphonuclear neutrophils (PMN), PMN lysates, or purified human PMN elastase. This increase was not inhibited by sodium azide, nor was it enhanced by incubation of cartilage with the strong oxidant hypochlorous acid. Chondrocyte-mediated matrix proteoglycan degradation in cartilage explants cultured in the presence of cytokines failed to increase antibody binding appreciably. The augmentation in antibody binding seen with PMN lysates was inhibited by the nonspecific serine-esterase inhibitor PMSF, but not by the divalent metal chelator EDTA. The elastase-specific inhibitor AAPVCMK […] 
Introduction
We recently observed that specific antibodies to type II collagen do not bind in appreciable amounts to the intact surface of articular cartilage, whereas antibodies to the minor collagen types V, VI, and IX do. These results suggest that the outermost cartilage surface layer prevented interaction of the antibodies with the major collagen type in articular cartilage. The present studies were designed to investigate the pathogenic mechanisms involved in the disruption of the cartilage surface layer in inflammatory arthritis.
Articular cartilage obtained from rabbits undergoing acute antigen-induced arthritis of 72 h duration showed a significant increase in binding ofanti-type II antibody to cartilage surfaces compared with normal control cartilage (P < 0.01). Augmentation of anti-type II binding was also observed upon in vitro incubation of bovine articular slices or intact rabbit patellar cartilage for I h with human polymorphonuclear neutrophils (PMN), PMN lysates, or purified human PMN elastase. This increase was not inhibited by sodium azide, nor was it enhanced by incubation of cartilage with the strong oxidant hypochlorous acid. Chondrocyte-mediated matrix proteoglycan degradation in cartilage explants cultured in the presence ofcytokines failed to increase antibody binding appreciably. The augmentation in antibody binding seen with PMN lysates was inhibited by the nonspecific serine-esterase inhibitor PMSF, but not by the divalent metal chelator EDTA. The elastase-specific inhibitor AAPVCMK also inhibited most of the PMN-induced increase in antibody binding, whereas the cathepsin G-specific inhibitor GLPCMK was much less effective. Incubation of intact cartilage with purified human PMN elastase indicated that this serine esterase could account for the increase in anti-type II collagen antibody binding to intact cartilage surfaces. These studies suggest that in an inflammatory response, PMN-derived elastase degrades the outer layer of articular cartilage, exposing epitopes on type II collagen. They also help clarify the pathogenic mechanisms involved in early articular cartilage damage in inflammatory joint diseases. (J. Clin. Invest. 1991. 87:1531-1536.) Key words: articular cartilage surface * cartilage damage -inflammation * PMN elastase * anti-collagen antibodies
The outermost layer of articular cartilage confers on this tissue some ofits peculiar biomechanical properties, probably including its unusual permeability characteristics to macromolecules (1, 2) . Little is known, however, about the physicochemical properties of this important layer. MacConaill (3) described a distinct amorphous surface layer detected by phase microscopy. This observation was interpreted by others to be a film of synovial fluid macromolecules (4) or highly oriented superficial collagen fibers (2). Stanescu et al. (5) described a thin, irregular, granular, electron-dense layer which contained anionic charges. This layer resisted extraction with high-ionic strength reagents, hyaluronidase, chondroitinase ABC, and keratanase, but was partially disrupted by collagenase and was removed by trypsin (6) . Moreover, the same group ofinvestigators reported that this superficial layer contained type I collagen in addition to type II, the main collagen type in cartilage (7) . Thus, it would appear that the most superficial layer of cartilage may include one or more unique proteins with a peculiar spatial organization. Because of this layer's anatomic location and susceptibility to enzymatic degradation, it would be expected to sustain damage early in the course of any pathologic process in which inflammatory cells appear in the joint cavity. Such damage might then lead to significant changes in the physical properties and nutritional characteristics of articular cartilage, contributing to the development offurther sustained injury to this tissue.
In the present studies, we took advantage of our recent observation indicating that specific antibodies to type II collagen, the main collagen type in cartilage, do not bind significantly to the surface of intact articular cartilage, whereas antibodies to the minor collagen types V, VI, and IX do (8) . From these observations it was concluded that the outermost layer ofcartilage is organized in such a fashion that it obscures the collagen type II epitopes, making them inaccessible to interact with antibodies in the articular cavity. This observation suggests that measurement of collagen antibody binding could be used to detect early and subtle damage to the proteinaceous outer layer, and to study the pathogenic mechanisms involved in the disruption of this layer.
In Hypochlorous acid was purified by vacuum distillation of a 5% solution of sodium hypochlorite, pH 7.5 (9) . Concentrations were determined by spectrophotometric analysis (E235 = 100 M-'cm-') (10) .
Human leukocyte elastase was purchased from Elastin Products Co. (Pacific, MO). The specific elastase inhibitor methoxysuccinyl-alaninealanine-proline-valine-chloromethylketone (AAPVCMK) and the cathepsin G inhibitor benzyloxy-carbonyl-glycine-leucine-phenylalanine-chloromethylketone (GLPCMK) ( 1 1) Acute antigen-induced arthritis. New Zealand White rabbits were immunized with 10 mg crystalline ovalbumin emulsified with 1 ml complete Freund's adjuvant (Sigma Chemical Co.) given intramuscularly and intradermally in several sites in the nape of the neck. 2-3 wk later, the animals were injected in the knee joints with 5 mg ovalbumin in 1 ml sterile pyrogen-free saline solution. The rabbits were sacrificed 72 h later, and the patellas and supracondylar cartilage were excised for incubation with the collagen antisera.
Experimental protocol. Bovine cartilage slices were cut with a scalpel into 4 X 4 mm squares weighing 20-30 mg each. Care was taken not to damage the articular surfaces. Quadruplicate tissue explants were washed with large volumes of HBSS for 30 min before incubation with the appropriate reagent at 4°C in l-ml-capacity screwcap sterile plastic tubes (Sarstedt Co., Princeton, NJ), or with a suspension of PMN activated with 100 ng/ml phorbol myristate acetate, as indicated under Results, for 1 h at 37°C with continuous slow tumbling (5 rpm). They were then transferred to 12 x 75-mm polystyrene tubes (Falcon; Becton-Dickinson Co., Lincoln Park, NJ), and washed three times for 20 min each with PBS solution, pH 7.2, containing 10% newborn calf serum (Gibco, Grand Island, NY) (PBS-NCBS) at 4VC with continuous tumbling. The tissues were then transferred back to fresh l-ml tubes for incubation with 0.5 ml of the rat sera at 1:100 dilutions in PBS-NCBS for 1 h at 4VC. The tissues were washed again as described above and then incubated with 0.5 ml of a 2-4 ug/ml solution of affinity-purified 1251I-goat anti-rat Ig, sp act 5 X 105-106 cpm/,gg, containing 0.1 M Nal, for 1 h. After three additional washes, the bound radioactivity was measured in a Packard Tricarb gamma scintillation spectrometer (Packard Instruments Co., Downers Grove, IL). Tissue wet weights were then obtained so that the results could be expressed as picograms anti-Ig bound per milligram tissue. The rat anticollagen sera used in the present experiments were selected by radioimmunoassay on the basis ofcomparable titers to their respective collagens and their lack ofcrossreactivity with the alternative collagen type (8) .
The rabbit patellas were treated in a similar fashion except that incubation with antisera was carried out in a volume of 4 ml. The cartilage was excised from the patellas after the last wash. In some experiments, anticollagen antibody binding to the intact articular cartilage was compared with patellar cartilage sliced before incubation with the antisera.
Cartilage organ culture. Quadruplicate bovine articular cartilage explants were cultured for 8 d with culture medium alone, with 100 U/ml interleukin 13, or with a 10% dilution of a supernatant obtained from phytohemagglutinin-activated human mononuclear cells (15) . After the 8-d incubation period, the tissue explants were treated as described above. Controls consisted of cartilage-explants kept at 4VC for the same period of time. Proteoglycan released by the explants was measured by the colorimetric method of Farndale et al. (16) .
Statistics. Analysis of significance was performed using unpaired two-tailed Student's t test.
Results
Initially, experiments were carried out to investigate the effects of acute arthritis on the availability of type II collagen epitopes on the intact surface of articular cartilage. Acute antigen-induced arthritis was induced in 18 rabbits in three separate experiments. The results shown in Table I compare binding of antisera to collagen types II and V, and control rat sera to intact patellar and sliced supracondylar cartilage obtained from normal and inflamed joints. As previously observed (8) x 105-2.5 x 106 PMN/ml. The effect of PMN incubation on the increase in collagen type II epitope availability could not be inhibited by sodium azide (results not shown). Similar results were obtained using intact or sliced rabbit cartilage (Table II) . In this experiment, binding of antibody to the intact cartilage surface increased fourfold.
One of the pathogenic mechanisms implicated in the process ofirreversible degradation ofarticular cartilage in rheumatoid arthritis and osteoarthritis involves degradation of matrix macromolecules -by cytokine-activated resident chondrocytes (15) . To investigate ifchondrocyte-mediated cartilage degradation results in increased binding of anti-type II collagen antibody to cartilage surfaces, we incubated bovine cartilage ex- effect, in agreement with our previous negative results using sodium azide to inhibit the antibody binding increase mediated with live PMN. These results excluded reactive oxygen radicals and enzymes capable ofdegrading acidic polysaccharides from consideration as possible factors responsible for the exposure of type II collagen epitopes on the articular cartilage surface, and suggested that proteases active at neutral pH may be responsible for these observations. This hypothesis was tested by treating the PMN lysate with a series of specific and nonspecific protease inhibitors in an attempt to block the increase in anticollagen antibody binding to cartilage treated with the lysate. As indicated in Table V , the specific elastase inhibitor AAPVMCK markedly inhibited the antibody binding increase mediated by the PMN lysate on both rabbit and bovine cartilage by 84.9 and 75.3%, respectively. Inhibition of metalloproteases with EDTA, or of cathepsin G with the specific inhibitor GLPCMK, failed to reduce binding appreciably, whereas the nonspecific esterase inhibitor PMSF showed an inhibitory effect comparable with that of AAPVCMK.
The role of elastase was confirmed in experiments involving treatment ofbovine or rabbit cartilage with purified human PMN elastase. Incubation of intact and sliced cartilage with 1 ,gg/ml elastase for 1 h significantly increased binding ofanticollagen antibodies to cartilage surfaces (Table VI) . The increase was particularly impressive in the intact patellar cartilage incubated with elastase, in which a fivefold increase in antibody 
Discussion
The present studies were prompted by our recent observation indicating that specific antibodies to type II collagen, the main collagen type in articular cartilage, failed to bind in significant amounts to the intact outer surface ofthis tissue, whereas significantly greater binding to intact articular cartilage was seen with antibodies to the minor collagen types V, VI, and IX (8).
This finding suggested that the outermost proteinaceous layer of cartilage might be organized in such a fashion so as to exclude type II collagen antigenic determinants from interaction with antibodies in the joint space. It is unlikely that this observation was due to lack ofcross-reactivity ofthe rat antisera with rabbit type II collagen because the cut surfaces of sliced rabbit cartilage bound significant amounts of antibody (Table I) . In fact, if correction is made for the antibody bound to intact cartilage surfaces, then anti-type II collagen bound roughly twice as much antibody as anti-type V. We reasoned that an increase in anti-type II collagen antibody binding to articular cartilage surfaces might be associated with early and subtle damage to the outer layer. The present studies were undertaken to identify the pathogenic mechanisms involved in the disruption of the outer layer of articular cartilage that results in increased binding of type II collagen antibodies to bovine and rabbit articular cartilage surfaces. The in vivo relevance ofthis phenomenon was investigated with articular cartilage obtained from rabbit kneejoints undergoing acute antigen-induced arthritis of 72 h duration. In these experiments, we used the entire patella as a source of intact cartilage because cut-tissue surfaces would of necessity reveal collagen antigenic sites not normally available for interaction with antibody. When cartilage slices were used, it was assumed that at least part of the observed increase in antibody binding was due to exposure of collagen antigenic sites on the cut surfaces of the tissue. The in vivo experiments with antigen-induced arthritis were consistent with our earlier findings that normal articular cartilage surfaces did not bind appreciable amounts ofanti-type II collagen antibodies, but did bind antitype V collagen (8) . In contrast, cartilage obtained from in-flamed joints showed a significant increase in binding of antitype II collagen antibodies when compared with control sera. Inflammation did not appear to increase the magnitude ofbinding of anti-type V collagen, suggesting that damage to the surface layer did not increase exposure of this collagen type. It is also possible that if there were an increase in accessibility of collagen type V epitopes, the proteases in the inflammatory fluid may have partially degraded them. The latter possibility is suggested by the consistent increase in binding of anti-type V collagen antibody to inflamed cartilage slices, which may have been due to an increase in type V collagen synthesis by the chondrocytes in the deeper cartilage layers in response to the inflammatory insult. Alternatively, the type V collagen epitopes on the cut surfaces may have been protected from protease digestion.
While investigating the pathogenic mechanisms involved in the disruption of the cartilage surface that resulted in increased anti-type II antibody binding, we observed consistent increases in antibody binding to cartilage with exposure of the tissues to as few as lO PMN/ml (Fig. 1 ), or to lysates derived from cell suspensions containing 2.5 X 105 PMN/ml (results not shown). This finding raised the question ofwhether one or more PMN-derived factors might be involved in damage to the proteinaceous outer layer.
The increase in antibody binding mediated by live PMN was not inhibited by sodium azide, nor was there an increase in antibody binding upon incubation of cartilage with the strong oxidant hypochlorous acid, which is normally generated by activated PMN (18) . These results suggest that reactive oxygen radicals are not among the PMN-derived factors that render articular cartilage more susceptible to binding anticollagen antibodies. Similar negative results were obtained with testicular hyaluronidase. This finding is consistent with the report of Stanescu et al. (6) , which indicated that hyaluronidase treatment of cartilage failed to remove the anionic charges present on the articular surface. This report (6) also indicated that trypsin treatment disrupted the proteinaceous layer, and it thus seemed plausible that PMN proteases active at neutral pH might be responsible for the damage ofthis layer in inflammation. Metalloproteases were ruled out by the inability ofEDTA to suppress antibody binding (Table V) , and by the failure of resident chondrocyte activation in the organ culture experiments (Table III) to increase antibody binding, in the face of clear evidence of matrix proteoglycan degradation and of increase in neutral proteinase secretion by the activated cells. Marked suppression ofthe increase in antibody binding by the nonspecific serine esterase inhibitor PMSF implicated one or both of the PMN serine esterases active at neutral pH: elastase and cathepsin G (19) . The use of peptidyl chloromethylketone compounds specific for each protease (1 1) implicated PMN elastase as the enzyme mainly responsible for the observed phenomenon..This conclusion was strengthened by the experiments in which highly purified human PMN elastase induced increased binding of type II collagen antibodies to cartilage.
Elastase is thought to be the most abundant protease in PMN, amounting to 1% ofthe total cellular protein (20) . Moreover, this enzyme has a broad substrate specificity (19) , and is able to degrade the terminal, nonhelical peptides and crosslinks of type II collagen (21) and cartilage proteoglycan (22) .
Pertinent to our observations are the findings of Janoff et al. (25) . Recent studies on the characterization of serine proteases contained in the azurophil granules of PMN indicate that in addition to elastase, another enzyme with similar characteristics may also constitute a major component of these granules (26) . It is of interest that this serine protease (proteinase 3 or myeloblastin) has recently been identified as a major autoantigen for the family of antineutrophil cytoplasmic antibodies associated with Wegener's granulomatosis (27) (32) . In the light of the: present findings, it is reasonable to conclude that the enhanced effects ofthe passively infused antibodies are due to the unveiling oftype II collagen epitopes by the adjuvant-induced arthritis, which results in increased binding of such antibodies to the articular surface. Our findings also support the notion that anticollagen antibodies may not play a primary pathogenic role in human disease. These antibodies have been detected in blood and synovial fluid in a variety of diseases where sustained injury to connective tissue is present (33) (34) (35) (36) (37) . Their possible modulating effects on chronic inflammatory arthritides might depend on their ability to bind to previously damaged cartilage surfaces (38) .
Little is known about the physicochemical properties ofthe outermost layer of articular cartilage. MacConaill (3) described an amorphous surface layer detected by phase microscopy, the lamina splendens. Other investigators have interpreted these findings as artifacts, either as synovial fluid macromolecules attached to the articular surface (4), or as an optical image created by the presence of highly oriented superficial collagen fibers (2). Stanescu et al. (5, 6) however, showed that the superficial, granular, anionic, electron-dense layer could resist extraction with high ionic strength reagents and polysaccharidases, but was removed by trypsin. The same investigator published evidence that this layer contained both type I and type II collagen (7) . It should be pointed out that these studies were done before the characterization of the additional minor collagen types in cartilage (38) , so that it is possible that the peptide chains derived from the cartilage surface demonstrated in that work may actually be part of the minor collagen types.
The present studies suggest that the use of immunologic probes such as anti-type II collagen antibodies, or antisera against unique proteins present on the surface of intact articular cartilage, may allow for the detection of early changes of the articular cartilage surface in inflammatory arthritis. Because of this layer's strategic anatomical location, its disruption in inflammatory states may lead to significant changes in the biomechanical properties and permeability characteristics of the underlying cartilage. Biochemical characterization of this structure will be an important step in the delineation of its function.
